- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05777525
Use of Essential Oils as Natural Therapies
Use of Essential Oils as Natural Therapies Against Dermatophytosis and New Diagnostic Techniques
Mycosis is defined as a fungal infection caused by the implantation of etiological agents that compromises the dermis and subcutaneous tissue.
Dermatophytosis is a fungal infection caused by dermatophytes, being the main cause of superficial mycoses and constituting an important public health problem.
The production or development of infections is due in any case to the loss of ability to protect the exterior of the skin epidermis and, in the case of nails, to the fact that the nail apparatus does not have cell-mediated immunity effective, thus being more susceptible to infection than other parts of the skin. Although these infections can be bacterial, fungal, or viral, the investigators will focus on fungal infections.
There are numerous studies that suggest the suitability of EOs as an alternative treatment for fungal infections.
Due to this, in this project the investigators will analyze one of the most important infections within the podiatric health of the population, in terms of its incidence, pathogenesis, diagnostic methods, etc., and for this our research will be focused on examining whether there is improvements in the skin of patients with dermatophytosis treated with cream enriched with natural oils, in our case tea tree oil, verified by ultrasound.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Mycosis is defined as a fungal infection caused by the implantation of etiological agents that compromise the dermis and subcutaneous tissue. The etiological agents can be filamentous fungi, yeasts and mold fungi, present in nature, in the soil, vegetation and in decomposing organic matter. Mycosis is among the most common form of infection in humans, with an approximate incidence of 20-25% of the world population.
Dermatophytosis is the fungal infection caused by dermatophytes, being the main cause of superficial mycoses and constituting an important public health problem. Dermatophytes are divided into three genera, having an affinity for and the ability to grow in keratinized tissues, such as hair, skin, and nails. Other fungal infections of the skin and appendages in humans may be caused by non-dermatophyte fungi, such as yeasts and mold fungi. Onychomycosis is dermatophytosis that affects the nails, this being one of the most frequent causes in the clinic, both in the dermatological field and in general medicine. In this type of infections, the most important thing is to know the agent that causes the infection, thus being able to establish a specific treatment. Currently, approximately 90% of toenail onychomycosis and 75% of all nail onychomycosis are caused by dermatophytes. The production or development of infections is due in any case to the loss of ability to protect the exterior of the skin epidermis and, in the case of nails, to the fact that the nail apparatus does not have cell-mediated immunity effective, thus being more susceptible to infection than other parts of the skin. Although these infections can be bacterial, fungal, or viral, the investigators will focus on fungal infections.
Various scientific articles have verified and confirmed that superficial fungal infection (tinea pedis, athlete's foot, tinea versicolor, etc.) is usually referred to the foot, due to its transmission through showers and shared materials, environmental humidity , etc.
There are numerous studies that suggest the suitability of EOs as an alternative treatment for fungal infections and the investigators found numerous studies that demonstrate the antifungal action of various commercial EOs in in vitro studies. Among the most studied EOs due to their antifungal activity, the following stand out: thyme (Thymus vulgaris), cinnamon (Cinnamomun zeylanicum) and tea tree (Melaleuca alternifolia), among many others.
Due to this, in this project we will analyze one of the most important infections within the podiatric health of the population, in terms of its incidence, pathogenesis, diagnostic methods, etc., and for this our research will be focused on examining whether there is improvements in the skin of patients with dermatophytosis treated with cream enriched with natural oils, in our case tea tree oil, verified by ultrasound.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Cáceres
-
Plasencia, Cáceres, Spain, 10600
- Raquel Mayordomo Acevedo
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- who is in the age range
- consent signature accepted
- not have allergies to the treatment
- not have chronic skin diseases
Exclusion Criteria:
- not meet any inclusion criteria
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Echography
Ultrasound skin measurements will be taken before and after the enriched cream treatment.
|
|
No Intervention: "Visiopor PP-34 camera"
Measurements of the skin will be taken by "Visiopor PP-34" camera before and after the treatment with enriched cream.
|
|
No Intervention: Mycological culture
Skin samples will be taken and analyzed by mycological culture before and after treatment with enriched cream
|
|
Experimental: treatment application
The essential oil enriched cream will be applied to study participants.
|
application of cream enriched with essential oil
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Appearance of the skin through the use of ultraviolet light through the processing of photographs obtained
Time Frame: 3 months
|
Data collection with Visiopor camera.
Measurement unit: occupied area
|
3 months
|
Skin thickness measured in millimeters through images obtained by ultrasound
Time Frame: 3 months
|
Data collection with ultrasound.
Measurement unit: millimeters
|
3 months
|
Taking mycological samples for subsequent cultivation on saboureaud agar
Time Frame: 3 months
|
take mycological samples to check for infection.
Measurement unit: positive/negative
|
3 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CreamAAT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Lesion
-
Memorial Sloan Kettering Cancer CenterRecruitingSkin Lesion | Mucosal LesionUnited States
-
Eun-ji KimCompletedSkin LesionKorea, Republic of
-
University Hospital, Strasbourg, FranceRecruiting
-
Halcyon DermatologyCompleted
-
University of California, IrvineNational Institute for Biomedical Imaging and Bioengineering (NIBIB)RecruitingSkin LesionUnited States
-
Emory UniversityCompleted
-
Northwestern UniversityCompleted
-
Pulse Biosciences, Inc.TerminatedSkin Lesion | Seborrheic Keratosis | Lesion Skin | Benign Skin TumorUnited States
-
Massachusetts General HospitalNot yet recruitingNevus | Skin Lesion
Clinical Trials on application of cream "La Chinata"
-
Hospices Civils de LyonNot yet recruitingHead and Neck Neoplasms | Carcinoma, Non-Small-Cell Lung | Colorectal NeoplasmsFrance
-
Medical University of SilesiaCompletedCannabis | Myofascial Pain | Temporomandibular Disorder | ElectromyographyPoland
-
Novartis PharmaceuticalsTerminatedCutaneous Squamous Cell Carcinoma in Situ (CSCCis)Belgium, Australia, United States
-
Laboratoires FILLMEDCompleted
-
GlaxoSmithKlineCompletedDenture RetentionUnited States
-
MC2 TherapeuticsCompletedPhotoallergyUnited States
-
Covis Pharma S.à.r.l.CompletedRaynaud's Phenomenon Secondary to Connective Tissue DiseaseUnited States
-
Phytotox SAWithdrawn
-
Necmettin Erbakan UniversityIstanbul UniversityCompletedNursing Caries | Neurological Disorder | Ecchymosis | Cryotherapy Effect | Periorbital Edema
-
Southern California University of Health SciencesCompletedHerpes SimplexUnited States